What is it about?
Tyrosine kinase-inhibitors are used to treat chronic myeloid leukaemia. In some people they can be stopped without the leukaemia returning. Why?
Featured Image
Why is it important?
Understanding why and how might help more people stop anti-leukaemia drugs.
Perspectives
Understanding this will help us understand other leukaemias and other cancers.
Robert peter Gale
Imperial College London
Read the Original
This page is a summary of: Therapy-free remission in chronic myeloid leukemia: possible mechanism, Expert Review of Hematology, March 2018, Taylor & Francis,
DOI: 10.1080/17474086.2018.1442213.
You can read the full text:
Contributors
The following have contributed to this page
